Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron

Journal of Pathology

Volumn 208, Issue 1, 2006, Pages 82-90

  Asare, George A ^a   Paterson, Alan C ^b   Kew, Michael C ^a   Khan, Shehnaz ^b   Mossanda, Kensese S ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

African dietary iron overload; Altered hepatic foci; Direct hepatocarcinogenicity; Ferrocene; Portal fibrosis

Indexed keywords

FERROCENE; GLUTATHIONE TRANSFERASE; IRON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIET SUPPLEMENTATION; HEMOCHROMATOSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FERROUS COMPOUNDS; IMMUNOHISTOCHEMISTRY; IRON; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR;

EID: 29744444731     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1875     Document Type: Article

References (53)

1. Bothwell TH, Bradlow BA. Siderosis in the Bantu. A combined histopathological and chemical study. Arch Pathol 1960;70:279-292.
2. Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1986;1:1310-1313.
3. Walker ARP, Arvidsson UB. Iron overload in the South African Bantu. Trans R Soc Trop Med Hyg 1953;47: 536-548.
4. Gordeuk VR. African iron overload. Semin Hematol 2002;39: 263-269.
5. Bothwell TH, Seftel H, Jacobs P, Torrance JD, Baumslag N. Iron overload in Bantu subjects. Studies on the availability of iron in Bantu beer. Am J Clin Nutrit 1964;14:47-51.
6. Gordeuk VR, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100.
7. McNamara L, MacPhail AP, Gordeuk VR, Hasstedt SJ, Rouault T. Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene? Br J Haematol 1998;102:1176-1178.
8. Beutler E, Barton JC, Ferlitti VJ, et al. Ferroportin 1 (SLC40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 2003;31:305-309.
9. Gordeuk VR, Caleffi A, Coradini E, Ferrara F, Jones RA, Castro O, Onyekwere O. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferriportin) gene. Blood Cells Mol Dis 2003;31:299-304.
10. McNamara L, Gordeuk VR, MacPhail AP. Ferroportin Q248H mutations in African families with dietary iron overload. J Gastroenterol Hepatol (in press).
11. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary haemochromatosis. N Engl J Med 1985;313:1256-1262.
12. Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, Berman MD. Primary hepatocellular carcinoma in idiopathic haemochromatosis after reversal of cirrhosis. Gastroenterology 1988;95:1399-1402.
13. Goh J, Callagy G, McEntee G, O'Keane JC, Bomford A, Crowe J. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and a review of the literature. Eur J Gastroenterol 1999;11:915-919.
14. Leone N, Volpes R, Carrera M, Pellicano R, De Paolis P, Fiorentino M, et al. Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and a literature review. Panminerva Med 2000;42:151-154.
15. Pelisse M, Gonzalez-Abraldes J, Navas M, Miquel B, Bruguera M. Hepatocellular carcinoma in a patient with hereditary haemochromatosis without cirrhosis. Gastroenterol Hepatol 2001;24:132-134.
16. Isaacson C, Seftel HC, Keeley KJ, Bothwell TH. Siderosis in the Bantu: the relationship between iron overload and cirrhosis. J Lab Clin Med 1961;58:845-853.
17. Higginson J. Primary carcinoma of the liver in Africa. Br J Cancer 1956;10:609-622.
18. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel G, Bothwell TH. Associations of iron overload in Africa and hepatocellular carcinoma and tuberculosis. Blood 1996;87:3479-3476.
19. Moyo VM, Makunike R, Gangaidzo IT, Gordeuk VR, McLaren CE, Khumalo H, et al. African iron overload and hepatocellular carcinoma. Eur J Haematol 1998;60:28-34.
20. Mandishona E, MacPhail PA, Gordeuk VR, Kedda M-A, Paterson AC, Rouault T, Kew MC. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 1998;27:1563-1566.
21. Plummer JL, Mackinnon M, Cmielewski PL, Williams P, Ahern WJ, Ilsley AH, de la M Hall P. Dose-related effects of dietary iron supplementation in producing hepatic iron overload in rats. J Gastroenterol Hepatol 1997;12:839-884.
22. Torrance JD, Bothwell TH. A simple technique for measuring storage iron concentrations in formalinized liver samples. S Afr Med J 1968;33:9-11.
23. Scheuer PJ, Lefkowitch J. Liver Biopsy Interpretation, 2nd edn. W B Saunders: London, 2000; 274.
24. Bannasch P, Frederick F, Becker FF, Busey W, Farber E, Firminger HI, Garner FM. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res 1975;35:3214-3223.
25. Pitot HC, Campbell HA, Maronpot R, Bawa N, Rizvi TA, Xu YH, et al. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 1989;17:594-611.
26. Narama A, Imaida K, Iwata H, Nakae D, Nishikawa A, Harada T. A review of nomenclature and diagnostic criteria for proliferative lesions in the liver of rats by a working group of the Japanese society of toxicologic pathology. Toxicol Pathol 2003;16:1-17.
27. Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouang J, Jouanolle H. Primary liver cancer in genetic haemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993;104:228-234.
28. Deugnier YM, Charalambous P, le Quilleuc D, Turlin B, Searle J, Brissot P, Poell LW. Preneoplastic significance of hepatic iron-free foci in genetic haemochromatosis: a study of 185 patients. Hepatology 1993;18:1363-1369.
29. Wanless IR, Callea F, Craig JR, Crawford JM, Desmet VJ, Farber E, Ferrell LD. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-993.
30. Tatematsu M, Tsuda H, Shirai T, Matsui T, Ito N. Placental glutathione S transferase (GST-P) as a new marker for hepatocarcinogenesis: in vivo short-term screening for hepatocarcinogenesis. Toxicol Pathol 1986;15:60-68.
31. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005;25:16-27.
32. Park CH, Bacon BR, Brittenham GM, Tavill AS. Pathology of dietary carbonyl iron overload in rats. Lab Invest 1987;57:555-563.
33. Iancu TC, Ward RJ, Peters TJ. Ultrastructural observation in the carbonyl iron fed rat: an animal model for haemochromatosis. Virchows Arch B 1987;53:208-217.
34. Ward RJ, Florence AL, Baldwin D, Abiaka C, Roland F, Ramsey MH, et al. Biochemical and biophysical investigations of the ferrocene iron-loaded rat. An animal model of primary haemochromatosis. Eur J Biochem 1991;202:405-410.
35. Dullman J, Wulfhekel U, Nielsen P, Heinrich HC. Iron overload of the liver by trimethyl hexanoyl ferrocene in rats. Acta Anat 1992;43:96-108.
36. Nielsen P, Heinrich HC. Metabolism of iron from (3,3,5-trimethylhexanoyl) ferrocene in rats. A dietary model for severe iron overload. Biochem Pharmacol 1993;45:385-391.
37. Smith PGH, Yeoh GCT. Chronic iron overload in rats induces oval cells in the liver. Am J Pathol 1996;149:389-398.
38. Pigeon C, Turlin B, Iancu TC, Leroyer P, Le Lan J, Deugnier Y, et al. Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice. J Hepatol 1999;30:926-934.
39. Kroes R, Garbis-Berkvens JM, de Vries T, Nesselrooy JHJ. Histopathological profile of a Wistar rat stock including a survey of the literature. J Gerontol 1981;36:259-279.
40. Deerberg F, Rapp KG, Pitterman W, Rehm S. Zum Tumourspektrum der han Wist-ratte. Z Versuchstierk 1980;22:267-280.
41. Ogawa K, Onoe T, Takeuchi M. Spontaneous occurrence of γ-glutamyl transpeptidase-positive hepatocytic foci in 105 week-old Wistar and 72 week-old Fischer 344 male rats. J Natl Cancer Inst 1981;67:407-412.
42. Ward JM, Henneman JR. Naturally-occurring age-dependent glutathione S-transferase pi positivity immunoreactive hepatocytes in ageing female F344 rat liver as potential promotable targets for non-genotoxic carcinogens. Cancer Lett 1990;31:187-195.
43. Schulte-Herman R, Timmermann-Trosiener I, Schuppler J. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumour production by nonmutagenic compounds. Cancer Res 1983;43:839-844.
44. Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K. Single GST-P-positive cells - putative initiated hepatocytes. Carcinogenesis 1987;8:483-486.
45. Kovazin R, Eldar T, Patya M, Vanichkin KI, Lander HM, Novogrodsky A. Ferrocene-induced lymphocyte activation and antitumour activity is mediated by redox-sensitive signaling. FASEB J 2003;17:467-469.
46. Madinaveitta JL. Ferrocenes as haematinics. Br J Pharmacol 1965;24:352-359.
47. Domarle O, Blampain G, Agnaniet H, Nzadiyabi T, Lebibi J, Brocard J, et al. In vitro antimalarial activity of a new organometallic analogue, ferrocene chloride. Antimicrob Agents Chemother 1998;42:540-544.
48. Itoh T, Shirakami S, Ishida N, Yamashita Y, Yoshida T, Kim HS, Wataya Y. Synthesis of novel ferrocenyl sugars and their antimalarial activities. Bioorg Med Chem Lett 2000;10:1657-1659.
49. Bomford A, Williams R. Long-term results of venesection therapy in idiopathic haemochromatosis. Q J Med 1976;45:611-623.
50. Milder MS, Cook JD, Stray S, Finch CA. Idiopathic haemochromatosis: an interim report. Medicine 1980;59:34-49.
51. Kew MC, Torrance JD, Derman DP, Simon M, MacNab GM, Charlton RW, Bothwell TH. Serum and tumour ferritin in primary liver cancer. Gut 1978;19:294-299.
52. Paterson AC, Kew MC, Herman AAB, Becker PJ, Hodkinson J, Isaacson C. Liver morphology in southern African Blacks with hepatocellular carcinoma: a study in an urban environment. Hepatology 1985;5:72-78.
53. Hall P. Pathological spectrum of alcoholic liver disease. In Alcoholic Liver Disease: Pathology and Pathogenesis, 2nd edn, Hall P (ed.). Edward Arnold: London, 1995; 54-58.